Müllers, Erik
AstraZeneca (Sweden)
4 papers on CoChatORCID 0000-0002-2176-3248
Most cited papers
- Verified
Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase
Müllers, E., Cascales, H. S., Jaiswal, H., Saurin, A. T., & Lindqvist, A. (2014) · Cell Cycle
Cancer-related Molecular PathwaysDNA Repair Mechanisms
Cited by 84
- Verified
Residual Cdk1/2 activity after DNA damage promotes senescence
Müllers, E., Silva Cascales, H., Burdova, K., Macurek, L., & Lindqvist, A. (2017) · Aging Cell
Telomeres, Telomerase, and SenescenceCancer-related Molecular Pathways
Cited by 56
- Verified
Cell Morphological Profiling Enables High-Throughput Screening for PROteolysis TArgeting Chimera (PROTAC) Phenotypic Signature
Trapotsi, M.-A., Mouchet, E., Williams, G., Monteverde, T., Juhani, K., Turkki, R., Miljković, F., Martinsson, A., Mervin, L., Pryde, K. R., et al. (2022) · ACS Chemical Biology
Protein Degradation and InhibitorsCell Image Analysis Techniques
Cited by 51
- Verified
The Foamy Virus Gag Proteins: What Makes Them Different?
Müllers, E. (2013) · Viruses
T-cell and Retrovirus StudiesHIV Research and Treatment
Cited by 46
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free